Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to Varian Medical Systems, Inc. in connection with its approximately A$1.6 billion acquisition of Sirtex Medical Limited. The transaction is subject to the approval of the Sirtex shareholders, the Federal Court of Australia and other customary closing conditions, including applicable regulatory approvals.
Varian Medical Systems is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Sirtex Medical is an Australia-based global life sciences company focused on interventional oncology therapies.
The Davis Polk corporate team includes partner Alan F. Denenberg and associate Andrew Basham. All members of the Davis Polk team are based in the Northern California office.